Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “P. Aeruginosa”

211 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 211 results

Testing effectiveness (Phase 2)Study completedNCT03218917
What this trial is testing

Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis

Who this might be right for
Non-Cystic Fibrosis Bronchiectasis
Insmed Incorporated 256
Not applicableStudy completedNCT00700050
What this trial is testing

Modulation by Sex Hormones of Inflammation and Susceptibility to Pseudomonas Aeruginosa in Cystic Fibrosis Airways

Who this might be right for
Cystic Fibrosis
The Hospital for Sick Children 28
Not applicableStudy completedNCT03963297
What this trial is testing

Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination

Who this might be right for
Antibiotic Resistant Strain
Fondation Hôpital Saint-Joseph 747
Testing effectiveness (Phase 2)UnknownNCT02116010
What this trial is testing

Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients

Who this might be right for
Wound Infection
Phagenix
Not applicableStudy completedNCT01616862
What this trial is testing

The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis

Who this might be right for
Pseudomonas AeruginosaCystic Fibrosis
Zafer Soultan 53
Large-scale testing (Phase 3)Looking for participantsNCT03581370
What this trial is testing

Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients with Ventilator Associated-pneumonia

Who this might be right for
Ventilator-associated Pneumonia
University Hospital, Toulouse 80
Large-scale testing (Phase 3)Study completedNCT01082367
What this trial is testing

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Who this might be right for
Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients
Novartis Pharmaceuticals 50
Not applicableUnknownNCT05642767
What this trial is testing

Molecular Detection Of Efflux Pump and Virulence Factors Genes in Pseudomonas Aeruginosa

Who this might be right for
Pseudomonas Aeruginosa
Sohag University 75
Large-scale testing (Phase 3)Study completedNCT00112359
What this trial is testing

International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

Who this might be right for
Cystic Fibrosis
Gilead Sciences 166
Testing effectiveness (Phase 2)Ended earlyNCT02096315
What this trial is testing

Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.

Who this might be right for
BronchiectasisLower Respiratory Infection
Polyphor Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00889967
What this trial is testing

Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"

Who this might be right for
Non-Cystic Fibrosis Bronchiectasis
Aradigm Corporation 95
Not applicableUnknownNCT04490447
What this trial is testing

Identification of Microbiome and Metabolome of Bronchiectasis in Chinese Population.

Who this might be right for
Bronchiectasis
Shanghai Pulmonary Hospital, Shanghai, China 160
Post-approval studies (Phase 4)Study completedNCT01519661
What this trial is testing

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Who this might be right for
Pulmonary InfectionsPseudomonas Aeruginosa in Cystic Fibrosis
Novartis Pharmaceuticals 157
Not applicableNo Longer AvailableNCT03395743
What this trial is testing

Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic

Armata Pharmaceuticals, Inc.
Not applicableUnknownNCT02102152
What this trial is testing

Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection

Who this might be right for
Bronchiectasis With Chronic Infection With Pseudomonas Aeruginosa
Rabin Medical Center 40
Not applicableLooking for participantsNCT06950892
What this trial is testing

Remote Sputum Collection in Cystic Fibrosis

Who this might be right for
Cystic FibrosisInfections
University of Pennsylvania 150
Early research (Phase 1)Study completedNCT02255760
What this trial is testing

Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults

Who this might be right for
MEDI3902 for Prevention of P. Aeruginosa Pneumonia
MedImmune LLC 56
Not applicableStudy completedNCT06548841
What this trial is testing

Development and Validation of (Bio)Sensors for the Identification of Pathogens

Who this might be right for
InfectionsInfection, BacterialInfection Viral+4 more
University of Bologna 149
Large-scale testing (Phase 3)Study completedNCT01563263
What this trial is testing

Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43

Who this might be right for
Pseudomonas Aeruginosa Infection
Valneva Austria GmbH 803
Early research (Phase 1)Looking for participantsNCT07709494
What this trial is testing

A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa

Who this might be right for
Healthy ParticipantsNon-cystic Fibrosis Bronchiectasis
Revagenix, Inc. 64
Next Page